搜尋
Edap Tms SA
EDAP添加自選
4.320USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
194.17M總市值
虧損本益比TTM
關鍵數據
--今開
0.000最高
0.00成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.15%換手率
4.320昨收
0.000最低
0.00成交額
虧損本益比靜
8.34市淨率
0.00%股息率 TTM
-40.33%ROA
5.05052週最高
1.43量比
-19.02M淨利潤
37.48M總股本
-0.8244每股盈餘TTM
-0.03Beta
-130.39%ROE
1.21052週最低
4.76%振幅
45.73%毛利率
194.17M總市值
-2.11回報/風險
5.52%風險率
TradingKey Edap Tms SA股票評分
單位: USD 更新時間: 2026-05-29操作建議
Edap Tms SA當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名101/206位。機構持股佔比非常高，近一月多位分析師給出公司評級為持有。最高目標價為5.83。中期看，股價處於平穩狀態。近一個月，市場表現很強，技術面和基本面綜合得分較高，很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Edap Tms SA評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
Edap Tms SA亮點
亮點風險
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
業績高增長
公司營業收入穩步增長，連續3年增長26.36%
業績增長期
公司處於發展階段，最新年度總收入70.53M美元
利潤高增長
公司淨利潤處於行業前列，最新年度總收入70.53M美元
估值合理
公司最新PE估值-5.24，處於3年歷史合理位
機構減倉
最新機構持股14.62M股，環比減少4.64%
分析師目標
基於
4
分析師
買入
評級
6.875
目標均價
+32.21%
漲幅空間
Edap Tms SA新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Edap Tms SA簡介
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
公司代碼EDAP
公司Edap Tms SA
CEORhodes (Ryan)
網址https://focalone.com/fr/accueil/
相關品種
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%熱門品種
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
常見問題
Edap Tms SA(EDAP)的當前股價是多少？
Edap Tms SA(EDAP)的當前股價是 4.32。
Edap Tms SA 的股票代碼是什麼？
Edap Tms SA的股票代碼是EDAP。
Edap Tms SA股票的52週最高點是多少？
Edap Tms SA股票的52週最高點是5.05。
Edap Tms SA股票的52週最低點是多少？
Edap Tms SA股票的52週最低點是1.21。
Edap Tms SA的市值是多少？
Edap Tms SA的市值是194.17M。
現在Edap Tms SA(EDAP)的股票是買入、持有還是賣出？
根據分析師評級，Edap Tms SA(EDAP)的總體評級為買入，目標價格為6.88。
Edap Tms SA(EDAP)股票的每股收益（EPS TTM）是多少
Edap Tms SA(EDAP)股票的每股收益（EPS TTM）是-0.78。